Joint Health in an Adult Population - PEA or Curcumin Compared to a Placebo in Arandomised, double-blinded study

RDC Global Pty Ltd0 个研究点目标入组 160 人开始时间: 2019年10月23日最近更新: 2021年3月1日

适应症

试验速览

暂无简介。

•Male and females 25-70 years old
•Reporting joint pain (not associated with acute injury or long-standing disease)
•Generally healthy
•Able to provide informed consent
•If female, must use either a prescribed form of birth control, are abstinent or post-menopausal
•Agree not to change current diet or exercise during the study
•Agree not to take any pain medication during the study

•Unstable or serious illness (e.g. kidney, liver, GIT, heart conditions, diabetes, thyroid gland
•function Malignancy)*
•Malignancy or treatment for malignancy within the previous 2 years
•Diagnosed rheumatoid arthritis, bursitis and/or gout
•Receiving/prescribed coumandin (Warfarin), heparin, daltaparin, enoxaparin or other
•anticoagulation therapy
•Serious mood disorders or neurological disorders such as MS
•Active smokers, nicotine, alcohol, drug abuse
•Chronic past and/or current alcohol use (more than 14 standard alcoholic drinks week)
•Allergic to any of the ingredients in active or placebo formula
•Known pregnant or lactating woman
•Any condition which in the opinion of the investigator makes the participant unsuitable for
•Participants who have participated in any other related clinical study during the past 1 month
•History of infection in the month prior to the study
•*An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.

发起方